These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2574281)

  • 1. Antiglucocorticoid actions of dehydroepiandrosterone and low concentrations in Alzheimer's disease.
    Svec F; Lopez A
    Lancet; 1989 Dec; 2(8675):1335-6. PubMed ID: 2574281
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiglucocorticoid effects of DHEA-S in Alzheimer's disease.
    Leblhuber F; Windhager E; Neubauer C; Weber J; Reisecker F; Dienstl E
    Am J Psychiatry; 1992 Aug; 149(8):1125-6. PubMed ID: 1344027
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of DHEA and DHEA-S in Alzheimer's disease.
    Adinoff B; Martin PR; Eckardt MJ; Linnoila M
    Am J Psychiatry; 1993 Sep; 150(9):1432-3. PubMed ID: 8352366
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia.
    Murialdo G; Barreca A; Nobili F; Rollero A; Timossi G; Gianelli MV; Copello F; Rodriguez G; Polleri A
    J Endocrinol Invest; 2001 Mar; 24(3):139-46. PubMed ID: 11314741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone sulphate in Alzheimer's disease.
    Lancet; 1990 Aug; 336(8712):449-50. PubMed ID: 1974985
    [No Abstract]   [Full Text] [Related]  

  • 6. Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease.
    Näsman B; Olsson T; Fagerlund M; Eriksson S; Viitanen M; Carlström K
    Biol Psychiatry; 1996 Mar; 39(5):311-8. PubMed ID: 8704061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased total 7 alpha-hydroxy-dehydroepiandrosterone in serum of patients with Alzheimer's disease.
    Attal-Khémis S; Dalmeyda V; Michot JL; Roudier M; Morfin R
    J Gerontol A Biol Sci Med Sci; 1998 Mar; 53(2):B125-32. PubMed ID: 9520908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease.
    Sunderland T; Merril CR; Harrington MG; Lawlor BA; Molchan SE; Martinez R; Murphy DL
    Lancet; 1989 Sep; 2(8662):570. PubMed ID: 2570275
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients.
    Young AH; Gallagher P; Porter RJ
    Am J Psychiatry; 2002 Jul; 159(7):1237-9. PubMed ID: 12091208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and urinary dehydroepiandrosterone in cancer.
    Sonka J; Vítková M; Gregorová I; Tomsová Z; Hilgertová J; Staś J
    Endokrinologie; 1973 Aug; 62(1):61-8. PubMed ID: 4274190
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate.
    Solerte SB; Ferrari E; Cuzzoni G; Locatelli E; Giustina A; Zamboni M; Schifino N; Rondanelli M; Gazzaruso C; Fioravanti M
    Dement Geriatr Cogn Disord; 2005; 19(1):1-10. PubMed ID: 15383738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different regulation of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzheimer's type.
    Dodt C; Dittmann J; Hruby J; Späth-Schwalbe E; Born J; Schüttler R; Fehm HL
    J Clin Endocrinol Metab; 1991 Feb; 72(2):272-6. PubMed ID: 1846870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum profile of dehydroepiandrosterone (DHEA) concentrations in DHEA-supplemented elderly subjects.
    Morganti S; Freddi M; Rebecchi I; Solerte B; Ferrari E; Ceda GP; Banchini A; Ablondi F; Valenti G; Ceresini G
    J Endocrinol Invest; 1999; 22(10 Suppl):77-8. PubMed ID: 10727057
    [No Abstract]   [Full Text] [Related]  

  • 14. DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial.
    Leblhuber F; Haller H; Steiner K; Fuchs D
    Neurology; 2004 Mar; 62(6):1030. PubMed ID: 15037728
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid.
    Dudas B; Hanin I; Rose M; Wülfert E
    Neurobiol Dis; 2004 Mar; 15(2):262-8. PubMed ID: 15006696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone sulphate in Alzheimer disease.
    Späth-Schwalbe E; Dodt C; Dittmann J; Schüttler R; Fehm HL
    Lancet; 1990 Jun; 335(8702):1412. PubMed ID: 1971699
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurosteroids: Cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics.
    Kim SB; Hill M; Kwak YT; Hampl R; Jo DH; Morfin R
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5199-206. PubMed ID: 14602750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone sulfate serum levels: no significance in diagnosing Alzheimer's disease.
    Ferrario E; Massaia M; Aimo G; Pallavicino di Ceva A; Fabris F
    J Endocrinol Invest; 1999; 22(10 Suppl):81. PubMed ID: 10727059
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationships between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls.
    Carlson LE; Sherwin BB; Chertkow HM
    Horm Behav; 1999 Jun; 35(3):254-63. PubMed ID: 10373337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner.
    Barger SW; Chavis JA; Drew PD
    J Neurosci Res; 2000 Nov; 62(4):503-9. PubMed ID: 11070493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.